Clinical trials
Terminated Lupus Erythematosus, Systemic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Novartis Pharmaceuticals | 2 |
| Base Therapeutics (Shanghai) Co., Ltd. | 1 |
| Bristol-Myers Squibb | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| Janssen Research & Development, LLC | 1 |
| Kezar Life Sciences, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Provention Bio, a Sanofi Company | 1 |
| TJ Biopharma Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 13 |
| Lupus Nephritis | 3 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Myositis | 1 |
| Proteinuria | 1 |
| Thrombocytopenia | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.